Christopher Peetz

CHIEF EXECUTIVE OFFICER

Christopher Peetz (CHIEF EXECUTIVE OFFICER) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Mirum Pharmaceuticals, Inc. (MIRM). The largest single filing was $3.8M of MIRM (40,985 sh × $91.98, as filed), executed Mar 16.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 8 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$16.2M

shares × price, as filed

Last traded

Sep 1

Filed Sep 3

Median ADV $83.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $25.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 8 filings

Sector per market data · by filing · past 12 months

Most traded names

MIRM

Mirum Pharmaceuticals, Inc. MIRM · 0 buys · 15 sells 15 filings

Recent filings

MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $2.5M
40,000 sh × $62.00
Exec Aug 11 2025
Filed Aug 12 2025 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $2.2M
40,000 sh × $55.25
Exec Aug 7 2025
Filed Aug 8 2025 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $1.2M
27,279 sh × $44.21
Exec Mar 17 2025
Filed Mar 18 2025 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $1.9M
40,000 sh across 2 lots
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $439K
9,102 sh × $48.22
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $328K
6,837 sh × $47.92
Exec Jan 24 2025
Filed Jan 27 2025 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $321K
7,489 sh × $42.82
Exec Jan 7 2025
Filed Jan 8 2025 · 5:30 PM ET